Cardiovascular Diseases Research in Michigan
Cardiovascular Diseases Research (93.837) awarded $460 million to recipients in Michigan in 364 grants from fiscal 2021 to 2025, 3.1% of the program's national total. Regents of the University of Michigan received the most, $356 million.
- Awarded in Michigan$460 million
- Awards364
- Share of the program3.1%
- Rank among states10th of 51
- National total$15 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 191 | $90.4 million |
| FY 2022 | 181 | $90.7 million |
| FY 2023 | 185 | $92.0 million |
| FY 2024 | 184 | $96.5 million |
| FY 2025 | 171 | $90.0 million |
Recipients in Michigan
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Regents of the University of Michigan | Colleges and universities | 279 | $356 million |
| Wayne State University | Colleges and universities | 25 | $35.0 million |
| Michigan State University | Colleges and universities | 15 | $28.4 million |
| Henry Ford Health System | Nonprofits | 6 | $8.8 million |
| Michigan Technological University | Colleges and universities | 9 | $4.8 million |
| Vantis Vascular Inc | Small businesses | 1 | $3.8 million |
| Michigan State University | Colleges and universities | 5 | $3.3 million |
| Nota Laboratories, Inc. | Small businesses | 2 | $3.2 million |
| Innovative Biotherapies, Inc. | Small businesses | 2 | $3.2 million |
| Oakland University | Colleges and universities | 5 | $2.3 million |
Open opportunities under this program
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 82 on the program page
Questions people ask
How much Cardiovascular Diseases Research money goes to Michigan?
$460 million from fiscal 2021 to 2025, across 364 awards. Michigan ranks 10th of 51 states and territories for this program.
Who receives Cardiovascular Diseases Research money in Michigan?
The largest recipient is Regents of the University of Michigan, with $356 million in 279 awards. Next are Wayne State University and Michigan State University.
Can organizations in Michigan apply now?
Yes, 82 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cardiovascular Diseases Research in other states
Other large programs in Michigan
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Temporary Assistance for Needy Families
- National School Lunch Program
- Commercial Technologies for Maintenance Activities Program
- Title I Grants to Local Educational Agencies
- Special Education Grants to States
- Child Care and Development Block Grant
- Head Start